3Leach C A,Hickey D M,Ife R J,et al.Lipoprotein-associated PLA2 inhibition-a novel,nonlipid lowering strategy for atherosclerosis therapy[J].Farmaco,2001,56(1-2):45-50.
4Witztum J L,Steinberg D.Role of oxidized low densit lipoprotein in atherosclerosis[J].J Clin Invest,1991,88(6):1785-1792.
5Zalewski A,Macphee C.Role of lipoprotein-associated phospholipase A2 in atherosclerosis:biology,epidemiology,and possible therapeutic target[J].Axterioscler Thromb Vasc Biol,2005,25(5):923-931.
6Oei H H,Sayed-Tabatabaei F A,Hofman A,et al.The association between angiotensin-converting enzyme gene polymorphism and coronary calcification.The Rotterdam Coronary Calcification Study.Atherosclerosis,2005,182 (1):169-173.
7Caslake M J,Packard C J,Suckling K E,et al.Lipoproteinassociated phospholipase A2,platelet-setivating facetor acetylhydrolase:apotential now risk factor for coronary artery disease[J].Atherosclerosis,2000,150(2):413-419.
8Tsimihodimos V,Karabina S A,Tambaki A P,et al.Altered distribution of platelet-activating facetor acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolsmia[J].J Lipid Res,2002,43(2):256-263.
9Cao Y,Stafforini D M,Zimmerman G A,et al.Expression of Plasma Platelet-activating Factor Acetylhydrolase Is Transcriptionally Regulated by Mediators of Inflammation[J].J Biol Chem,1998,273(7):4012-4020.
10Satoh K,Yoshida H,Imaizumi T,et al.Platelet-aetivating factor acetylhydrolase in plasma lipoproteins from patients with ischemic stroke[J].Stroke,1992,23(8):1090-1092.
